Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients

American Journal of Kidney Diseases

Volumn 42, Issue 4, 2003, Pages 761-773

  Kalantar Zadeh, Kamyar ^a   McAllister, Charles J ^b   Lehn, Robert S ^b   Lee, Grace H ^b   Nissenson, Allen R ^b   Kopple, Joel D ^b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b NONE

Author keywords

Cytokines; Inflammation; Malnutrition inflammation complex syndrome (MICS); Malnutrition inflammation score (MIS); Protein energy malnutrition; Recombinant human erythropoietin (EPO)

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FERROUS GLUCONATE; INTERLEUKIN 6; IRON DEXTRAN; LACTATE DEHYDROGENASE; PREALBUMIN; RECOMBINANT ERYTHROPOIETIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANALYSIS OF VARIANCE; ANEMIA; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; COVARIANCE; DIALYSIS; DOSE RESPONSE; FEMALE; HUMAN; INFLAMMATION; IRON BINDING CAPACITY; IRON THERAPY; KIDNEY FAILURE; LOGISTIC REGRESSION ANALYSIS; LYMPHOCYTE COUNT; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MALNUTRITION INFLAMMATION COMPLEX SYNDROME; MALNUTRITION INFLAMMATION SCORE; NUTRITION; NUTRITIONAL VALUE; PROTEIN CALORIE MALNUTRITION; QUANTITATIVE ANALYSIS; REFRACTORY ANEMIA; SCORING SYSTEM;

EID: 0141508878     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(03)00915-6     Document Type: Article

References (56)

1. National Kidney Foundation I, Kidney-Dialysis Outcomes Quality Initiative: K/DOQI Clinical practice guidelines: Anemia of chronic kidney disease. Am J Kidney Dis 37:S182-238, 2001 (suppl 1)
2. Tong EM, Nissenson AR: Erythropoietin and anemia. Semin Nephrol 21:190-203, 2001
3. Nissenson AR, Strobos J: Iron deficiency in patients with renal failure. Kidney Int Suppl 69:S18-21, 1999
4. Madore F, Lowrie EG, Brugnara C, et al: Anemia in hemodialysis patients: Variables affecting this outcome predictor. J Am Soc Nephrol 8:1921-1929, 1997
5. Kalantar-Zadeh K, Hoffken B, Wunsch H, Fink H, Kleiner M, Luft FC: Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era. Am J Kidney Dis 26:292-299, 1995
6. Gunnell J, Yeun JY, Depner TA, Kaysen GA: Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 33:63-72, 1999
7. Kalantar-Zadeh K, Don BR, Rodriguez RA, Humphreys MH: Serum ferritin is a marker of morbidity and mortality in hemodialysis patients. Am J Kidney Dis 37:564-572, 2001
8. Van de Vyver FL, Visser WJ, D'Haese PC, et al: Iron overload and bone disease in chronic dialysis patients. Nephrol Dial Transplant 5:781, 1990
9. Thamer M, Richard CM, Klinkmann J, Ivanovich P, Lang G, Cotter DJ: Use of clinical guidelines for treatment of anemia among hemodialysis patients. Artif Organs 24:91-94, 2000
10. Barany P, Divino Filho JC, Bergstrom J: High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients. Am J Kidney Dis 29:565-568, 1997
11. Kalantar-Zadeh K, Kleiner M, Dunne E, et al: Total iron-binding capacity-estimated transferrin correlates with the nutritional subjective global assessment in hemodialysis patients. Am J Kidney Dis 31:263-272, 1998
12. Stenvinkel P, Barany P: Anaemia, rHuEPO resistance, and cardiovascular disease in end-stage renal failure: Links to inflammation and oxidative stress. Nephrol Dial Transplant 17:32-37, 2002 (suppl 5)
13. Kalantar-Zadeh K, Kopple JD: Relative contribution of malnutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis 38:1343-1350, 2001
14. Kalantar-Zadeh K, Kopple J: Inflammation in renal failure, in UpToDate (10.2). Boston, MA, UpToDate, Inc, 2003
15. Kalantar-Zadeh K, Block G, Humphreys M, Kopple J: Reverse epidemiology of cardiovascular risk factor in maintenance dialysis patients. Kidney Int 63:793-803, 2003
16. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH: Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am Soc Nephrol 12:2797-2806, 2001
17. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH: A malnutrition-inflammation score is-correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 38:1251-1263, 2001
18. Fried L, Bernardini J, Piraino B: Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patients. Am J Kidney Dis 37:337-342, 2001
19. Beddhu S, Bruns FJ, Saul M, Seddon P, Zeidel ML: A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med 108:609-613, 2000
20. Kalantar-Zadeh K, Supasyndh O, Lehn RS, McAllister CJ, Kopple JD: Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V greater than 1.20. J Ren Nutr 13:15-25, 2003
21. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347:1557-1565, 2002
22. Erbagci AB, Tarakcioglu M, Aksoy M, et al: Diagnostic value of CRP and Lp(a) in coronary heart disease. Acta Cardiol 57:197-204, 2002
23. Pecoits-Filho R, Barany P. Lindholm B, Heimburger O, Stenvinkel P: Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 17:1684-1688, 2002
24. Stenvinkel P, Heimburger O, Jogestrand T: Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: Association with Chlamydia pneumoniae seropositivity. Am J Kidney Dis 39:274-282, 2002
25. Beutler B, Cerami A: The biology of cachectin/TNF - A primary mediator of host response. Ann Rev Immunol 7:625-655, 1989
26. Hayashi K, Hasegawa K, Kobayashi S: Effects of angiotensin-converting enzyme inhibitors on the treatment of anemia with erythropoietin. Kidney Int 60:1910-1916, 2001
27. United States Renal Data System: US Department of Public Health and Human Services, Public Health Service, National Institutes of Health, Bethesda, 2001
28. Goicoechea M, Martin J, de Sequera P, et al: Role of cytokines in the response to erythropoietin in hemodialysis patients. Kidney Int 54:1337-1343, 1998
29. Sitter T, Bergner A, Schiffl H: Dialysate related cytokine induction and response to recombinant human erythropoietin in haemodialysis patients. Nephrol Dial Transplant 15:1207-1211, 2000
30. Voulgari PV, Kolios G, Papadopoulos GK, Katsaraki A, Seferiadis K, Drosos AA: Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis. Clin Immunol 92:153-160, 1999
31. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM: The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia: Kidney Int 62:1524-1538, 2002
32. Stenvinkel P: The role of inflammation in the anaemia of end-stage renal disease. Nephrol Dial Transplant 16:36-40, 2001 (suppl 7)
33. Kalantar-Zadeh K, Luft FC, Humphreys MH: Moderately high serum ferritin concentration is not a sign of iron overload in dialysis patients. Kidney Int 56:758-759, 1999
34. Miller CB, Jones RJ, Piantadosi S, Abeloff MD, Spivak JL: Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 322:1689-1692, 1990
35. Jelkmann W, Pagel H, Wolff M, Fandrey J: Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci 50:301-308, 1992
36. Means RT Jr, Krantz SB: Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 80:1639-1647, 1992
37. Schooley JC, Kullgren B, Allison AC: Inhibition by interleukin-1 of the action of erythropoietin on erythroid precursors and its possible role in the pathogenesis of hypoplastic anaemias. Br J Haematol 67:11-17, 1987
38. Jongen-Lavrencic M, Peeters HR, Rozemuller H, et al: IL-6-induced anaemia in rats: Possible pathogenetic implications for anemia observed in chronic inflammations. Clin Exp Immunol 103:328-334, 1996
39. Hurot JM, Cucherat M, Haugh M, Fouque D: Effects of L-camitine supplementation in maintenance hemodialysis patients: A systematic review. J Am Soc Nephrol 13:708-714, 2002
40. Navarro JF, Mora C: In-depth review effect of androgens on anemia and malnutrition in renal failure: Implications for patients on peritoneal dialysis. Perit Dial Int 21:14-24, 2001
41. Brox AG, Zhang F, Guyda H, Gagnon RF: Subtherapeutic erythropoietin and insulin-like growth factor-1 correct the anemia of chronic renal failure in the mouse. Kidney Int 50:937-943, 1996
42. Brown MS, Shapiro H: Effect of protein intake on erythropoiesis during erythropoietin treatment of anemia of prematurity. J Pediatr 128:512-517, 1996
43. Bergstrom J, Lindholm B: Malnutrition, cardiac disease, and mortality: An integrated point of view. Am J Kidney Dis 32:834-841, 1998
44. Ritz E, Vallance P, Nowicki M: The effect of malnutrition on cardiovascular mortality in dialysis patients: Is L-arginine the answer? Nephrol Dial Transplant 9:129-130, 1994
45. Bellantone R, Doglietto GB, Bossola M, Pacelli F, Negro F, Crucitti F: Validity of serum albumin, total lymphocyte count, and weight loss in predicting postoperative nutrition-associated complications. Nutrition 6:264-266, 1990
46. Forse RA, Rompre C, Crosilla P, D Ot, Rhode B, Shizgal HM: Reliability of the total lymphocyte count as a parameter of nutrition. Can J Surg 28:216-219, 1985
47. Grzegorzewska AE, Leander M: Lymphocyte subset counts in continuous ambulatory peritoneal dialysis patients in relation to administration of recombinant human erythropoietin and angiotensin-converting enzyme inhibitors. Adv Perit Dial 18:6-11, 2002
48. Grzegorzewska AE, Leander M: Lymphocyte subsets in the course of continuous ambulatory peritoneal dialysis. Adv Perit Dial 17:10-14, 2001
49. Carvounis CP, Manis T, Coritsidis G, Dubinsky M, Serpente P: Total lymphocyte count: A promising prognostic index of mortality in patients on CAPD. Perit Dial Int 20:33-38, 2000
50. Lowrie EG, Lew NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458-482, 1990
51. Bologa RM, Levine DM, Parker TS, et al: Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 32:107-114, 1998
52. Kaysen GA: The microinflammatory state in uremia: Causes and potential consequences. J Am Soc Nephrol 12:1549-1557, 2001
53. Kaysen GA: Inflammation nutritional state and outcome in end stage renal disease. Miner Electrolyte Metab 25:242-250, 1999
54. Kaysen GA, Dubin JA, Muller HG, Rosales LM, Levin NM, HEMO Study Group: The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. Kidney Int 58:346-352, 2000
55. Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J: Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 15:953-960, 2000
56. Nejjari M, Couvelard A, Mosnier JF, et al: Integrin up-regulation in chronic liver disease: Relationship with inflammation and fibrosis in chronic hepatitis C. J Pathol 195:473-481, 2001